By Dawn Kawamoto – The U.S. Department of Justice faces a Monday deadline, in which it either lets the deal progress or makes a second request for information as part of a formal investigation into the proposed buyout. For Oracle, antitrust opposition, as well as PeopleSoft’s “poison pill” anti-take
Read More - Register for Free Membership
